Author:
Walker Adam J.,Price J. Blair,Borreggine Kristin,Sutor Shari L.,Gogos Andrea,McGillivray Jane A.,Frye Mark A.,Tye Susannah J.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health
Reference45 articles.
1. Smith, D. F. Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk. Front. Psychiatry 4, 1–5 (2013).
2. Daban, C., Vieta, E., Mackin, P. & Young, A. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr. Clin. 28, 469–480 (2005).
3. Stetler, C. & Miller, G. E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73, 114–126 (2011).
4. Nemeroff, C. B. Prevalence and management of treatment-resistant depression. J. Clin. Psychiatry 68, 17 (2007).
5. Iwai, T. et al. Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice. Behav. Brain Res. 243, 153–157 (2013).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献